COMPANY

Kenai Therapeutics

HQ: Cambridge, MA source · kenaitx.com ↗

Keywords: cell therapy neurology iPSC Parkinson's disease Idiopathic Parkinson´s Disease Parkinson's Disease RNDP-001

Location: Cambridge, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Jul 17, 2025 Trial start Phase 1/Phase 2: A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease source ↗

2027-09 (ESTIMATED) · Phase 1/Phase 2 · A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease · NCT07106021

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07106021	A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease	Phase 1/Phase 2	Active, not recruiting	Jul 17, 2025	2027-09 (estimated)